Filing Details
- Accession Number:
- 0000899243-16-022949
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-06-15 17:00:22
- Reporting Period:
- 2016-06-13
- Filing Date:
- 2016-06-15
- Accepted Time:
- 2016-06-15 17:00:22
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1583648 | Pieris Pharmaceuticals Inc. | PIRS | Services-Commercial Physical & Biological Research (8731) | 300784346 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1645577 | S. Stephen Yoder | C/O Pieris Pharmaceuticals, Inc. 255 State Street, 9Th Floor Boston MA 02109 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-06-13 | 6,000 | $1.68 | 6,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.680 to $1.687, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges sent forth in this footnote.